发明名称 E2F AND CANCER THERAPY
摘要 <p>This invention provides a composition for inhibiting tumor cell growth comprising effective amount of the peptide HHHRSLH or derivative thereof. This invention provides a composition comprising an amount of the peptide HHHRSLH or derivative thereof effective to inhibit the activity of transcription factor E2F. This invention provides a method for inhibiting tumor cell growth comprising contacting cells with effective amount of the peptide HHHRSLH or derivative thereof. This invention provides a method for inhibiting tumor growth comprising contacting cells with effective amount to inhibit the activity of transcription factor E2F. This invention provides a method of inhibiting tumor cell growth in a subject comprising administering to the subject and effective amount of the peptide HHHRSLH or derivative thereof.</p>
申请公布号 WO2003051312(A2) 申请公布日期 2003.06.26
申请号 US2002040355 申请日期 2002.12.17
申请人 发明人
分类号 主分类号
代理机构 代理人
主权项
地址